Floatz logo

METHOTREXATE

Ischaemic Stroke

NHS Greater Glasgow and ClydeSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Ischaemic Stroke cohort.

Asset / SponsorPhaseRating
MERCAPTOPURINE ANHYDROUS
NHS Greater Glasgow and Clyde
Phase 4BB
Allopurinol
NHS Greater Glasgow and Clyde
Phase 4BB
LEVODOPA
Singapore General Hospital
Phase 3BB
Benserazide
Singapore General Hospital
Phase 3BB
Ctx Dp
ReNeuron Limited
Phase 2B

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →